Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis ProductNews DeskJuly 29, 20260 Processa Pharmaceuticals is reshaping its pipeline with the acquisition of Vidya Therapeutics, a clinical-stage biotech whose main asset is a…